CTAGCAAATATTTTTGTAAGCAAT.-3' as an antisense primer for A668G in the leptin receptor gene. 22, 23 These primers yielded PCR products of 242 base pairs (bp), 213 bp, and 367 bp in length, respectively. The reaction was conducted in a total volume of 20 μl containing: 40 ng of template DNA, 4 pM of each primer, PCR buffer containing 1.5 mM MgCl 2 , 2.5 μM each dNTP (MBI Fermentas, United States), and 0.5 U of Taq polymerase (MBI Fermentas, United States). The amplification was performed with initial denaturation at 94ºC for 5 minutes, and then 36 cycles: denaturation at 94ºC for 20 seconds, annealing at 54ºC (leptin gene) and 58ºC (leptin receptor genes) for 40 seconds, and extension at 72ºC for 40 seconds. The final 72ºC incubation was extended by 8 minutes. For restriction fragment length polymorphism assays, a PCR product was incubated at 37ºC for 3 hours with 1 U Cfo I, Hae III and Hpa II, respectively. The fragments were separated by electrophoresis on 2% agarose gel, stained with ethidium bromide. Results were recorded with photographs of gels in UV light.
The PCR product of amplification containing -2548G wild-type allele was cleaved into 181 bp and 61 bp fragments. Thus leptin (LEP) -2548A allele was identified by lack of Cfo I restriction site. Substitution of adenine by guanine at 326 nucleotide of leptin receptor gene (LEPR) resulted in the formation of Hae III restriction site. The G326 allele was cleaved into 186 bp and 27 bp fragments, while the wild-type A326 allele was not cleaved. In the case of LEPR, the PCR product representing A668 allele was cleaved by Hpa II into 242 bp and 125 bp fragments, and the wild-type G668 allele was identified by the lack of Hpa II restriction site.
statistical analysis Distribution of values of particular variables was examined using the Shapiro-Wilk test. The values were log-transformed because of skewed distribution. In all analyses of leptinemia, a logarithm of leptin concentrations, which showed a normal distribution, was used. The same transformation was applied for all variables with non-normal distribution (TAbLE 1) . The Student's t-test was used for the comparison between groups; if the number of groups was 2 or more (like in the case of genotypes), the analysis of variance (ANOVA) was applied. For a single variable analysis, the Pearson linear correlation was used. An optimal model of multiple regression (containing variables responsible for most of variability of leptinemia) was chosen. All analyses were performed using STATISTICA 6.1.
REsuLTs
The anthropometric and bio chemical para meters of the study population are presented in TAbLE 1. Compared with women, men were taller and heavier, had lower waist-hip ratio, while waist circumference was similar. Women had significantly greater TFM and serum leptin concentrations, but lower BMC.
Based on these results, it was concluded that leptin may decrease bone formation (via the central and sympathetic nervous system). 3, 4 The relationship between serum leptin concentrations and BMD in humans has already been examined. A number of studies have shown a weak positive or no correlation between these two para meters. 5-13 However, other authors have shown a negative correlation between leptin and BMD. [14] [15] [16] [17] [18] There may be at least two reasons for this discrepancy. Only in some of these studies the mean values of body mass index (BMI) exceeded 30 kg/m 2 , and in obese patients the concentration of leptin in serum 1 and in cerebral fluid 19 is significantly higher than in subjects with normal body mass. Therefore, it is possible that higher leptin concentrations may exert a more potent effect on bone formation in obese patients than in lean ones. Another possibility is that these results might have been influenced by a number of factors that had not been examined, for example differences in leptin serum concentrations and/or function dependent on leptin and/or leptin receptor gene polymorphisms. The most widely studied and most functional are the polymorphisms of G(-2548)A leptin or A326G (K109R) and A668G (Q223R) leptin receptor genes. 20, 21 The aim of this study was to assess the effect of G(-2548)A leptin or A326G and A668G leptin receptor gene polymorphisms on serum leptin concentrations and on BMD and bone mineral content (BMC) in obese patients.
PATIENTs ANd mEThOds A total of 72 obese patients (BMI >30 kg/m 2 ) were included in the study. Hypertension was present in 53% of the patients. Subjects with diabetes and clinically relevant coronary heart disease were excluded. In all subjects blood samples were withdrawn in the morning after overnight fasting to measure serum creatinine, glucose, lipids, leptin, and insulin concentrations. The basic characteristics of the examined subjects are presented in TAbLE 1.
Serum leptin concentrations were determined by radioimmunoassay (Linco Research Inc., United States). Total fat mass (TFM), total BMC and BMD were assessed using dual energy X-ray absorptiometry (Lunar DPX-L, GE, United States) of the total body. The study was approved by the local Ethics Committee and was performed in accordance with the Declaration of Helsinki. Informed consent was obtained from every participant.
Genot yping Genomic DNA was amplified by polymerase chain reaction (PCR) with primers flanking polymorphic regions: 5'-TTTCCTGTAATTTTCCCGTGAG-3' as a sense primer and 5'-AAAGCAAAGACAGGCATAAA -3' as an antisense primer for G(-2548)A in the leptin gene, 5'-CTTTTGCCTGCTGGACTCTC.-3' as a sense primer and 5'-TAAAGAATTTACTGTTGAAACAAATGGC -3' as an antisense primer for A326G in the leptin receptor gene and 5'-TCCTGCTTTAAAAGCCTA ATCCAGTATTT-3' as a sense primer and 5'-AG is produced predominantly by white adipose tissue. This fact implies a strong positive correlation between serum leptin concentration and fat tissue mass, which had been documented previously and confirmed also in this study.
In line with a number of studies 14 -18 but in contrast to many others, 4-13 we observed a negative correlation between serum leptin concentration and bone mass (BMC). We have no data concerning the leptin concentration in cerebrospinal fluid in these patients. It is known, however, that a leptin concentration in cerebrospinal fluid in obese patients is only slightly higher in comparison with lean subjects, despite a much higher serum concentration of this hormone.
19 It might be speculated that even a slight increase in leptin concentrations in cerebrospinal fluid that occurs in obese patients is sufficient to activate TAbLE 2 shows the frequency of particular alleles. ANOVA did not reveal any significant differences between the para meters of the body mass composition (TFM, lean mass, BMC) or BMD in relation to genotype. A single variable analysis showed a positive correlation of serum leptin concentration with BMI, but negative with BMC. A multiple regression analysis showed independent correlations of leptinemia with sex, TFM, BMC, and the presence of -2548 A allele of the leptin gene (TAbLE 3) . Together, the above-mentioned parameters are responsible for 83% variability in serum leptin concentrations (TAbLE 3) . dIsCussION High body mass (related mainly to high fat mass) is one of the factors exerting a positive effect on bone turnover, causing higher bone mineralization in obese patients. Leptin Abbreviations: BMC - bone mineral content, BMD - bone mineral density, BMI - body mass index, HDL - high-density lipoprotein, LDLlow-density lipoprotein, TFM - total fat mass, WHR - waist-hip ratio 2002; 17: 1896-1903. a pathway in the central nervous system, decreasing bone formation via the sympathetic nervous system. 1, 4 A multivariate analysis showed that serum leptin concentrations are associated with sex, the presence of the LEP (-2548)A allele, higher TFM, and lower total body BMC. Together, these para meters are responsible for 83% of leptin concentration variability.
Previous studies showed positive and negative correlations of leptinemia and the presence of the (-2548)A allele. 24, 25 In obese adolescent girls, a positive correlation of obesity and the (-2548)G allele was shown, and serum leptin concentration was 25% lower in subjects with AA genotype. 25 In contrast, Hoffstedt et al. 21 showed that in nonobese subjects, the presence of AA genotype correlated positively with serum leptin levels.
Despite these discrepancies, it might be concluded that G(-2548)A leptin gene polymorphism may influence leptin levels, and as a confounding factor should be assessed in all the studies that examine the leptin levels.
The K109R and Q223R leptin receptor gene polymorphisms showed no relationship with leptin levels, which is in line with the results of a meta--analysis conducted by Paracchini et al. 20 Our study has a number of limitations. It was impossible to assess the body mass of the examined subjects prior to the study. However, all study subjects reported that their weight was stable over the previous 5 years. We may assume that also the fat mass was stable over that time. As leptin production depends mainly on the amount of white adipose tissue, we assume that also leptin levels were rather stable during the previous 5 years. Another limitation concerns the interpretation of a negative relationship between leptinemia and BMC or BMD -it should take into account the effect of immobilization on osteogenesis in obese patients. Obesity-induced low physical activity could be one of the main factors that impair bone formation in obese patients. It cannot be excluded that this factor may also affect an inverse correlation between BMC or BMD and leptinemia. Moreover, the study group was relatively small, which precluded a separate multiple regression analysis in women and men and limited the reliability of the results.
In conclusion, serum leptin concentrations in obese patients are independently and negatively Abbreviations: LEP (-2548)A - presence of allele A in (-2548) position of the leptin gene, others - see TAbLE 1 
